ACTIVE

Metaptys

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result218 k €+20,5 %over 1 year

Gross margin1,3 M €+4,2 %over 1 year

Equity1,3 M €+20,0 %over 1 year

Workforce7,3 ETP-11,0 %over 1 year

Identity

Source · BCE/KBO

Metaptys is a Public limited company incorporated in 2014. Its main activity is: Other professional, scientific and technical activities n.e.c.. Its registered office is in Leuven. It employs on average 7,3 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0554.664.311
Incorporation: 04/06/2014
Legal form: Public limited company
Registered office: Gaston Geenslaan 3
3001 Leuven · FlandreSee on map
Contributed capital: 232 053,00 €
Latest accounts: 31/12/2025
Average workforce: 7,3 ETP

Activities (NACE)

74909Other professional, scientific and technical activities n.e.c.· main 74999Other professional, scientific and technical activities n.e.c.71209Technical testing and analysis 71209Technical testing and analysis 72101Research and experimental development on natural sciences and engineering 72109Research and experimental development on natural sciences and engineering+2

Joint committees (2)

Contacts

1 public detail availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 11 filings

Trend over 11 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	1,3 M €	+4.2%	1,2 M €	-46.7%	2,3 M €	+2854%	-84,7 k €	-211%	-27,2 k €
EBITDA	382,8 k €	+4.5%	366,2 k €	-67.6%	1,1 M €	+517%	-270,8 k €	-860%	-28,2 k €
Operating result	224,5 k €	+17.9%	190,4 k €	-80.3%	966,2 k €	+424%	-298,3 k €	-958%	-28,2 k €
Net result	218 k €	+20.5%	180,9 k €	-81.0%	950,6 k €	+411%	-305,9 k €	-105%	6,6 M €
Balance sheet
Equity	1,3 M €	+20.0%	1,1 M €	+19.9%	907,2 k €	+2187%	-43,5 k €	-117%	262,5 k €
Total assets	1,6 M €	+6.7%	1,5 M €	-4.7%	1,6 M €	+57.1%	1 M €	+282%	267,6 k €
Cash	1,2 M €	+10.1%	1,1 M €	+38.8%	760,3 k €	+160%	292,9 k €	+17.5%	249,3 k €
Debts	329 k €	-20.0%	411,4 k €	-41.2%	700 k €	-34.3%	1,1 M €	+20545%	5,2 k €
Other
Workforce	7,3 ETP	-11.0%	8,2 ETP	-27.4%	11,3 ETP	+54.8%	7,3 ETP		–

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ADP Ventures0764.416.616Represented by Alexander DEPAUW	Director15/02/2026 → 15/05/2031
KINCON0773.398.816Represented by Matthias VAN WOENSEL	Director09/08/2023 → 15/05/2029
MARA CONSULTING0717.880.370Represented by Matthias DE WITTE	Director23/12/2021 → 17/05/2027

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Sascon0749.581.752Represented by Sandra SCHOORS	Director27/10/2021 → 2022 accounts
DROIA INVEST SARepresented by Janwillem NAESENS	Director19/05/2020 → 2020 accounts
WEPAVEN0828.052.277Represented by Janwillem NAESENS	Managing director16/12/2019 → 2019 accounts
axis advice0894.930.314Represented by Lionel DE HEMPTINNE	Director03/06/2019 → 2019 accounts

Other companies at this address

Gaston Geenslaan 3 3001 Leuven

Company	CBE no.
AstriVax Therapeutics● Active	0787.990.881
AUGUSTINE THERAPEUTICS● Active	0722.705.230
COULTREON BIOPHARMA● Active	1019.429.814
K5 Therapeutics● Active	0757.718.072
Montis Biosciences● Active	0730.979.429
Perseus Biomics● Active	0650.946.412
QUOMAK● Active	0448.488.111
ReWind Therapeutics● Active	0682.626.216
Stichting Administratiekantoor Coultreon● Active	1040.853.946
Tavira Therapeutics● Active	0802.591.262
VEDRA THERAPEUTICS● Active	1039.565.628

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/05/2026	24/07/2025	30/08/2024	22/08/2023	26/07/2022	19/08/2021
General meeting	15/05/2026	30/06/2025	29/07/2024	07/08/2023	19/07/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 11 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	15/05/2026	22/05/2026	Dutch	PDF
Abridged model	31/12/2024	30/06/2025	24/07/2025	Dutch	PDF
Abridged model	31/12/2023	29/07/2024	30/08/2024	Dutch	PDF
Abridged model	31/12/2022	07/08/2023	22/08/2023	Dutch	PDF
Abridged model	31/12/2021	19/07/2022	26/07/2022	Dutch	PDF
Abridged model	31/12/2020	30/06/2021	19/08/2021	Dutch	PDF
Abridged model	31/12/2019	15/05/2020	17/06/2020	Dutch	PDF
Abridged model	31/12/2018	28/06/2019	21/08/2019	Dutch	PDF
Abridged model	31/12/2017	15/05/2018	27/09/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	31/08/2017	Dutch	PDF
Abridged model	31/12/2015	17/05/2016	23/06/2016	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ADP Ventures0764.416.616Represented by Alexander DEPAUW	Director15/02/2026 → 15/05/2031
KINCON0773.398.816Represented by Matthias VAN WOENSEL	Director09/08/2023 → 15/05/2029
MARA CONSULTING0717.880.370Represented by Matthias DE WITTE	Director23/12/2021 → 17/05/2027

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Sascon0749.581.752Represented by Sandra SCHOORS	Director27/10/2021 → 2022 accounts
DROIA INVEST SARepresented by Janwillem NAESENS	Director19/05/2020 → 2020 accounts
WEPAVEN0828.052.277Represented by Janwillem NAESENS	Managing director16/12/2019 → 2019 accounts
axis advice0894.930.314Represented by Lionel DE HEMPTINNE	Director03/06/2019 → 2019 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates06/05/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates29/12/2023
ONTSLAGEN - BENOEMINGEN
PDF
Registered office16/11/2022
MAATSCHAPPELIJKE ZETEL
PDF
Other04/08/2022
DIVERSEN
PDF
Registered office05/05/2022
MAATSCHAPPELIJKE ZETEL
PDF
Mandates25/02/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/11/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/10/2021
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings11 filings

Mandates

ADP Ventures

KINCON

MARA CONSULTING

Sascon

DROIA INVEST SA

WEPAVEN

axis advice

Onko

Xia

LAURENS G. THEUNIS

201420152016201720182019202020212022202320242025202620272028202920302031

Metaptys

Gaston Geenslaan 3, 3001 Heverlee

Director

Chairman of the board of directorsManaging director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Gaston Geenslaan 3, 3001 HeverleeCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00119556
Da Vincilaan 1, 1930 Zaventem	accounts 2021	Accounts 2021 · 2022-20232447

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
MetaptysCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00119556

Events

2025
Annual accounts 2025218 k €↑
2024
Annual accounts 2024180,9 k €↓
2023
Annual accounts 2023950,6 k €↑
2022
Annual accounts 2022-305,9 k €↓
2021
Annual accounts 20216,6 M €↑
2020
Annual accounts 20205,8 M €↑
2019
Annual accounts 2019-1,7 M €↓
2018
Annual accounts 2018529,4 k €↑
2017
Annual accounts 2017-449,6 k €↑
2016
Annual accounts 2016-1 M €↑
2015
Annual accounts 2015-2,4 M €
04/06/2014
IncorporationPublic limited company

Metaptys

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events